2:00 pm - 5:00 pm
Arrival and Check-in
3:30 pm - 3:45 pm
Introductory Comments by GRC Site Staff / Welcome from the GRS Chair
3:45 pm - 4:30 pm
Keynote Session: Cell Fate Disease Modulation by Extracellular Vesicles
Margherita Alba Carlotta Pomatto (University of Turin, Italy)
3:45 pm - 4:15 pm
Peter Quesenberry (Brown University / Rhode Island Hospital, USA) "Cell Fate Disease Modulation by Extracellular Vesicles"
4:15 pm - 4:30 pm
4:30 pm - 6:00 pm
6:00 pm - 7:00 pm
7:30 pm - 9:30 pm
Heterogeneity of EVs: Diverse Biogenetic Pathways? / Molecular Characterization of EV Populations and Biological Activity: Considerations for EV Source and Method of Isolation
Cutting-edge research illuminating interesting and mechanistically-defined functions of EVs in inter-cellular communication will be presented as well as new methods of EV isolation.
Gerardo Mauleon Ramos (University of Chicago, USA)
7:30 pm - 7:50 pm
David Meckes (Florida State University College of Medicine, USA) "The NCI-60 Cancer Cell Line Panel Provides New Insights into Extracellular Vesicle Biogenesis and Cargo Selection"
7:50 pm - 8:00 pm
8:00 pm - 8:20 pm
Cristiana Spinelli (McGill University, Canada) "Molecular Subtypes and Differentiation Programs of Glioma Stem Cells as Determinants of Extracellular Vesicle Profiles and Endothelial Cell Stimulating Activities"
8:20 pm - 8:30 pm
8:30 pm - 8:50 pm
Kilean Lucas (University of Rochester, USA) "Exosome Purification Using Silicon Nanomembranes in Microfluidic Tangential Flow Filtration"
8:50 pm - 9:00 pm
9:00 pm - 9:20 pm
Sujay Ramanathan (Drexel University College of Medicine, USA) "Role of Immune Cell-Derived Exosomes in Chronic Pain and Inflammation"
9:20 pm - 9:30 pm
7:30 am - 8:30 am
9:00 am - 11:00 am
Therapeutic EVs: Harnessing the Biology of EVs for Cell-Free Tissue Regeneration and Cancer Interventions / Next-Gen Therapeutic EVs: Engineered EVs with Enhanced Cargo-Loading and Targeting
Extracellular vesicles have shown an ability to mediate tissue regeneration in a number of injury settings. Conversely, malignant EVs are now implicated in devastating cancer hallmarks such as metastasis. The newest strategies harnessing or targeting EVs for therapeutic interventions will be presented.
Meadhbh Brennan (Harvard University, USA)
9:00 am - 9:20 am
Rafael Lindoso (Federal University of Rio de Janeiro, Brazil) "Mesenchymal Cells and Hypoxia: Exploring the Role of Extracellular Vesicles in Kidney Diseases Treatment"
9:20 am - 9:30 am
9:30 am - 9:50 am
Theo Borgovan (Brown University / Rhode Island Hospital, USA) "Extracellular Vesicles Shape the Leukemic Microenvironment"
9:50 am - 10:00 am
10:00 am - 10:20 am
Kyle Mentkowski (University at Buffalo, USA) "Development of a Cardiomyocyte Targeting Delivery System Utilizing Cardiosphere-Derived Cell Exosomes"
10:20 am - 10:30 am
10:30 am - 10:50 am
Alexis Forterre (Stanford University School of Medicine, USA) "Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation"
10:50 am - 11:00 am
11:00 am - 12:30 pm
Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pm - 1:30 pm
1:30 pm - 2:30 pm
Mentorship Component: Clinical and Commercial Considerations of EV Therapies
Scott Ferguson (University at Buffalo, USA)
1:30 pm - 2:30 pm
Clinical and Commercial Considerations of EV Therapies
Dana Larocca (AgeX Therapeutics, Inc, USA)
Catherine Planey (Mantra Bio, USA)
James Thornton (Codiak BioSciences, USA)
2:30 pm - 3:00 pm
Fill in GRS Evaluation Forms